Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$312.46
—
Mkt Cap $6.05B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (26 analysts)
$339.43
Range $326.00 – $358.00
Implied Upside
+8.6%
Consensus $339.43 vs current $312.46